# Bio-Rad Finalizes Acquisition of Stilla Technologies in July 2025

> ma · REPORTED · 2025-07-01

Bio-Rad Laboratories finalized its acquisition of Stilla Technologies, a French biotechnology firm, in July 2025, expanding its life science tools portfolio with Stilla's digital PCR and droplet technology capabilities. The deal strengthens Bio-Rad's position in the growing digital PCR market for genomic analysis.

About Bio-Rad Laboratories: Bio-Rad Laboratories is a US-based life science and clinical diagnostics company offering instruments, reagents, and software for genomics, proteomics, and diagnostics research and clinical applications.

- Company: Bio-Rad Laboratories
- Sector: life-science tools
- Primary source: https://www.openpr.com/news/4451119/worldwide-factors-influencing-the-rapid-evolution-of-the-life

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.